Gerresheimer AG (DE:GXI)
XETRA:GXI
Want to see DE:GXI full AI Analyst Report?
GXI Stock Chart & Stats
€28.12
€0.20(0.29%)
At close: 4:00 PM EST
€28.12
€0.20(0.29%)
Day’s Range― - ―
52-Week Range€14.83 - €52.00
Previous CloseN/A
Volume5.61K
Average Volume (3M)538.00K
Market Cap
€875.24M
Enterprise Value€3.10B
Total Cash (Recent Filing)€145.87M
Total Debt (Recent Filing)€2.31B
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Jul 14, 2026EPS Estimate
0.65Next Dividend Ex-DateN/A
Dividend Yield0.15%
Share Statistics
EPS (TTM)0.67
Shares Outstanding34,540,000
10 Day Avg. Volume723,177
30 Day Avg. Volume537,996
Financial Highlights & Ratios
PEG Ratio-2.73
Price to Book (P/B)1.71
Price to Sales (P/S)1.27
P/FCF Ratio-19.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€21.57Price Target Upside-23.30% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)2.63
Revenue Forecast (FY)€2.37B
Bulls Say, Bears Say
Bulls Say
EBITDA MarginThe EBITDA margin for PPG showed some growth, driven by increased demand for RTF vials and expansion in moulded glass margins.
Order BooksOrder books for tubular glass are robust, suggesting potential incremental revenue growth.
Primary Packaging Glass PerformancePrimary Packaging Glass showed 15% sequential quarter-on-quarter growth, leading to a beat at EBITDA driven by a stronger 4Q margin.
Bears Say
Free Cash FlowFree cash flow showed a significant negative change, driven by changes in net working capital, raising concerns among investors.
Organic GrowthOrganic growth in the first quarter was lower than expected, showing a decline compared to consensus estimates.
Plastics & Devices SegmentPlastics & Devices segment numbers came in below expectations, disappointing given this segment is considered the core growth vertical.
Gerresheimer News
GXI FAQ
What was Gerresheimer AG’s price range in the past 12 months?
Gerresheimer AG lowest stock price was €14.83 and its highest was €52.00 in the past 12 months.
What is Gerresheimer AG’s market cap?
Gerresheimer AG’s market cap is €875.24M.
When is Gerresheimer AG’s upcoming earnings report date?
Gerresheimer AG’s upcoming earnings report date is Jul 14, 2026 which is in 30 days.
How were Gerresheimer AG’s earnings last quarter?
Gerresheimer AG released its earnings results on Apr 16, 2026. The company reported €0.32 earnings per share for the quarter, the consensus estimate of €0.32 by €0.
Is Gerresheimer AG overvalued?
According to Wall Street analysts Gerresheimer AG’s price is currently Overvalued.
Does Gerresheimer AG pay dividends?
Gerresheimer AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.15%. See more information on Gerresheimer AG dividends here
What is Gerresheimer AG’s EPS estimate?
Gerresheimer AG’s EPS estimate is 0.65.
How many shares outstanding does Gerresheimer AG have?
Gerresheimer AG has 34,540,000 shares outstanding.
What happened to Gerresheimer AG’s price movement after its last earnings report?
Gerresheimer AG reported an EPS of €0.32 in its last earnings report, expectations of €0.32. Following the earnings report the stock price went up 19.435%.
Which hedge fund is a major shareholder of Gerresheimer AG?
Currently, no hedge funds are holding shares in DE:GXI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gerresheimer Stock Smart Score
Company Description
Gerresheimer AG
Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its Plastics & Devices segment provides a variety of drug administration tools, such as inhalers, insulin pen systems, prefillable syringes, and diagnostic systems, for the pharmaceutical, biotech, diagnostics, and medical technology sectors. This division also manufactures plastic containers, closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and related accessories for solid, liquid, and ophthalmic applications, alongside bottles for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging products for the pharmaceutical and cosmetics industries, including infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; and miniature bottles for liquid food, spices, spirits, fragrances, deodorants, skincare, and wellness products. Lastly, the Advanced Technologies division focuses on developing intelligent drug delivery systems, like micro pumps, designed to enable the self-administration of medication for conditions such as Parkinson's disease or heart failure, serving its pharmaceutical and biotech clients.
GXI Stock 12 Month Forecast
Average Price Target
€21.57
▼(-23.30% Downside)
Technical Analysis
Options Prices
Currently, No data available
---